EMERGING ISSUES | COVID-19 | EVENTS | CONTACT

Exploratory Immunologic Differences in Cord Blood from Infants Born into Farming Environments Compared to Nonfarming Environments in MESA

Project Description

View All Funded Pilot Projects

2012-2014

Early farm exposure, including prenatal exposure, is associated with increased mRNA expression of innate immune receptors (TLR2, TLR4, CD14) in peripheral blood mononuclear cells (PBMC). Moreover, epidemiologic studies from multiple continents have found rural farming environments are protective for development of allergic diseases, with a proposed mechanism of skewing toward proinflammatory cytokine responses.

One potential explanation for these findings is that pre- and post-natal stimulation of the innate immune system is necessary for optimal immune maturation. Cross-sectional studies on cord blood of term newborns found both pre- and post-natal environmental exposures are significantly associated with unique patterns of immunologic responses. Specifically, the immune response of infants born into farming environments is associated with increased production of proinflammatory cytokines determined from in vitro culture supernatants after culture with TLR agonists. We have unpublished data showing that Wisconsin farm children in the Marshfield Epidemiology Research Area (MESA) are at significantly lower risk for developing allergic disease and clinically significant respiratory viral illnesses. To date, an immunologic profile that allows protection from clinically significant illnesses has not been defined nor has the TLR-mediated cytokine response been characterized at the cellular level in infants from farming environments.

UPDATE 2015:
Our large NIH grant is in its third year of funding. We have reached 75% of our enrollment goal. We have submitted separate proposals to fund the microbiome analysis (pending) and will submit competitive renewal to the NIH to continue to follow this important and unique birth cohort.

Wisconsin Infant Study Cohort

WISC LogoOur research group has been awarded a $5 million NIH award to continue this work with a larger number of infants and in a prospective manner. In addition to monitoring immune maturation, this larger study will monitor respiratory infection frequency and severity, development of allergic diseases (for example, atopic dermatitis), and collection of individual and environmental samples for future microbiome analysis.

Wisconsin farm children in the Marshfield Epidemiology Research Area (MESA) are at significantly lower risk for developing allergic disease and clinically significant respiratory viral illnesses.

Presentations

  • Seroogy C. et. al. Pilot Project Exploratory Immunologic Differences in Cord Blood from Infants Born into Farming Environments Compared to Non farming Environments in MESA, UMASH Annual Forum, April 17, 2013, Saint Paul MN
  • Oral presentation: Use of Multi-parameter Flow Cytometry to Determine Immune Phenotypes Associated with Decreased Respiratory Illnesses and Allergic Disease, Great Lakes International Imaging and Flow Cytometry Association (GLIIFCA) annual meeting, Oconomowoc, WI Sept 19-21, 2014.
  • Poster presentation: Use of Multi-Parameter Flow Cytometry to Determine Cord Blood Innate Immune Function Associated with Prenatal Farming Exposure, AAAAI, Houston, TX Feb 19-23, 2015

Project Personnel

PRINCIPAL INVESTIGATOR
Photo of Christine Seroogy MD

Christine Seroogy, MD

Associate Professor Department of PediatricsUniversity of Wisconsin Madison
Phone: 608-263-2652

Project News

 

ADDITIONAL FUNDING

Our research group was awarded a $5 million NIH award to continue this work with a larger number of infants and in a prospective manner (U19 AI104317 PI: Gern; Co-I: Seroogy).  In addition to monitoring immune maturation, this larger study will monitor respiratory infection frequency and severity, development of allergic diseases (for example, atopic dermatitis), and collection of individual and environmental samples for future microbiome analysis.

Wisconsin Infant Study Cohort

Update as of August 2015: Our large NIH grant is in its third year of funding. We have reached 75% of our enrollment goal. We have submitted separate proposals to fund the microbiome analysis (pending) and will submit competitive renewal to the NIH to continue to follow this important and unique birth cohort.